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Abstract
Background: Relapse is one of the main challenges that must be tackled in the drug addiction treatment. Different
factors contribute to the relapse process but it remains unclear how relapse occursin women. Describing the relapse
phenomenon in women might be of interest to practitioners and academics. The aim of this study was to explore the
relapse experiences of Iranian women with a substance use disorder.
Methods: Qualitative in-depth interviews were conducted with women with a substance use disorder. The interviews
contained open-ended questions regarding relapse experiences during previous treatment. Interviews were digitally
recorded. Data were analyzed using the content analysis method.
Results: In total, 20 women who use drugs took part in the study. The mean age of the women was 34.57 (age
range = 9.6 years), and the minimum age of participants was 23 years. The following five main themes were explored:
socioeconomic backgrounds, physical complications of drug withdrawal, psychological burden of drug withdrawal,
family atmosphere, and cultural factors. The findings highlighted the different treatment needs in women with a
substance use disorder.
Conclusions: Based on the interviews, it seems necessary to develop female-specific comprehensive treatment
programs by putting more emphasis on pain treatment intervention, relapse prevention, the diagnosis and treatment
of mental disorders, couples counseling, and financial support. Furthermore, policymakers should be committed to
providing a nonjudgmental social environment to remove or reduce stigma of women with drug use problems.
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Background
Substance abuse is a major national concern in Iran; ac-
cording to the Iranian Drug Control Headquarters (2018),
2.8 million Iranians are addicted to illicit drugs [1]. Some
studies suggest that 9.6% of Iranian addicts are women [2,
3]. Also, according to the Iranian Ministry of Health and
Medical Education, the male/female ratio of substance use
disorder is 8:1 [4].
Studies have revealed that the percentage of women
who use drugs in addiction treatment is very low [5, 6].
Women often encounter various personal, social, cultural,
and structural barriers to entering treatment, such as a
lack of treatment for pregnant women, low level of educa-
tion, psychiatric disorders, history of trauma, stigma, dis-
crimination, shame, poverty, child care duties, low social
support, lack of services in accordance with women’s
needs, high treatment cost, and rigid treatment schedules
[5, 7–9]. Dolan indicated that only 20% of Iranian women
who are dependent on illicit drugs receive addiction treat-
ment services [9]. In another study, this rate was even
lower: 10% [2]. In Iran, most clients who seek treatment
are men, so developing a treatment regimen that is tai-
lored to women is not a priority. However, a male-
orientated treatment program might ignore some of the
needs of female drug users [10]. The outcomes are not
promising because addiction treatment services do not ad-
dress women’s needs [11]. Relapse is one of the main
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challenges that need to be tackled in drug addiction treat-
ment and is caused by a combination of individual,
physiological, situational, and sociocultural factors [12–
14]. In a country with a high burden of addiction—like
Iran—increasing retention in drug treatment, particularly
the retention of women with a substance use disorder,
could also lead to reduced HIV risk [8, 15]. Furthermore,
the results of this study might be useful for identifying
high-risk situations leading to drug use and relapse among
women. This will help therapists design appropriate re-
lapse prevention interventions.
Using a qualitative design, the aim of this study was to
explore the relapse experiences of Iranian women with a
drug use disorder.
Methods
Participants
This study was conducted in Sanandaj city. Sanandaj is
the capital of the Kurdistan province. It is located in
northwestern Iran and is the second largest Kurdish city
[17]. From March to July 2017, we conducted 23 in-depth
qualitative interviews with women with a substance use
disorder. Three interviews were excluded because the par-
ticipants did not complete the interview due to personal
reasons. Fourteen women were undergoing methadone
maintenance treatment (MMT) during the interview. The
participants were randomly selected from five MMT
clinics (two patients per governmental clinic) and one
MMT clinic in the central prison in Sanandaj city (four
patients). Six additional women were recruited from a
medium-term residential center that provides treatment
services that typically last less than a month and that are
based on self-help and a 12-step recovery program. The
inclusion criteria in this study were that women (a) were
using illicit drugs, (b) had been diagnosed as drug
dependent, (c) had no mental health problems, and (d)
had past relapse experiences.
In this study, relapse was defined as self-reported drug
use after previous treatment and the return to drug use.
To gain rich and varied data, we applied a purposive sam-
pling technique so that participants with varying socioeco-
nomic backgrounds, various types of drug experiences,
different age groups, and varying marital statuses are
represented in the study. Sampling continued until data
saturation was reached [18]. An institutional review board
of the Kurdistan University of Medical Sciences approved
this study. [IR.14/23312]. Written informed consent was
obtained from all participants.
Data collection
The data were collected using in-depth interviews. The
corresponding author conducted all the interviews. The
interviewer (TP) has received professional training from
qualitative method experts in several workshop and is
experienced in designing and conducting quality in-
depth interviews and focus group discussions (including
proper guide development and interviewing/moderating
skills and techniques) with vulnerable groups, like
women with a substance use disorder.
To accumulate more detailed information, semi-
structured, open-ended interviews were conducted with
participants. The interview guide was developed based on
the literature [16–18] and piloted with 3 interviews. The
interviewer followed a guide that aimed to encourage par-
ticipants to explore and discuss their views and experi-
ences about relapse regarding substance use. The interview
guide included (1) the demographic characteristics of par-
ticipants; (2) the history of the illicit drug use; (3) the his-
tory of addiction treatment attempts and the number and
kind of treatment, such as MMT, buprenorphine, or opium
tincture; (4) the history of the number of relapses to illicit
drug use; (5) the experiences of relapse; (6) the identifying
factors related to relapse to illicit drug use; and (7) the rea-
sons of returning to illicit drug use. The interview guide is
presented in Appendix A.
We focused on each of the expressed experiences of
returning to illicit drug use in replies to the following
open-ended and non-directive questions: “How many
times you have been in treatment before?” “What do you
most like or dislike?” “Did it impact your using behav-
ior?” “How?” “Would you please explain more?” After
each question, participants were encouraged to elaborate
on what they had said. For example, they were asked,
“What do you mean?” to obtain a deeper understanding
of their behaviors. The interviews were conducted at
MMT centers and at the central prison. Interview ses-
sions were held in private situations, and participants
were told that they could end the interview at any time.
Each interview lasted between 90 and 120 min. All inter-
views were digitally audio recorded and then transcribed
by the researchers.
Data analysis
This study was inspired by Graneheim and Lundman’s
(2004) approach to qualitative content analysis, which
focuses on manifest and latent data content. Analysis of
what the content displays deals with the content features
and refers to the visible, obvious parts, referred to as the
obvious content. In contrast, analysis of what the con-
tent discusses deals with the connection part and con-
tains an explanation of the main concept of the text,
discussed as the hidden content. Both obvious and hid-
den content deal with explanation, but the explanations
differ in depth and level of abstraction [15]. Data ana-
lysis was performed during data collection. More specif-
ically, data analysis began with the data-gathering
process. Each interview was transcribed and analyzed
before the next interview.
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The analysis process was carried out in the following
stages. First, we reached an understanding of the data by
reading and rereading the transcribed text. Second, we ex-
tracted the unit meanings. Third, data analysis was contin-
ued by applying line-by-line coding (i.e., labeling of a
meaning unit), and codes were generated through frequent
discussions between investigators. Fourth, the meaning
units (i.e., the constellation of words or statements that re-
late to the same central meaning) were labeled with a code
based on their content. Finally, based on codes with similar
meanings, themes and subthemes were generated. After
this, all codes that were included in the aim of the study
were compared, similarities were determined, and codes
were sorted into categories (i.e., groups of content that
share a commonality) [15, 19].
All transcripts were imported into the MAXQDA soft-
ware. Overall, five key themes and 32 subthemes emerged
as main factors related to relapse among Iranian women
with a substance use disorder. The framework is presented
in Table 2.
As a means of validation, all interview transcripts and
the codes that emerged were randomly offered to some
of the women, and we asked about their opinions of the
meaning of each code. When conflicting opinions arose,
the women’s corrective notes were used. Additionally,
the interview transcriptions were made anonymous and
were offered to investigators who did not participate in
this study but who had experience with qualitative re-
search as external observers. We requested that they
check the coding process’s accuracy.
Ethics
Approval for conducting the study was granted by the
Ethics Committee of Kurdistan University of Medical
Sciences, Sanandaj, Iran. All women were informed that
their participation in this study was voluntary, that their
privacy would be maintained, and that no participants’
names would be used in any publications resulting from
the study. Informed written consent was gained from
each woman.
Results
In total, 20 women with a substance use disorder took
part in the study. The mean age of the women was
34.57 years (age range = 9.6 years, minimum age = 23
years), and most of them (70%) were married. The study
participants’ characteristics are presented in Table 1.
Overall, five major themes relevant to the purpose of
this study were identified: (1) physical complications of
drug withdrawal, (2) psychological burden of drug with-
drawal, (3) family atmosphere, (4) socioeconomic condi-
tions, and (5) cultural factors. For more details, see.
Table 2. The mean length of time since relapse was 53
days (range = 4–97 days). The substances mainly used by
the participants included opium and opium juice (55%),
amphetamine (5%), heroin (15%), crack heroin (20%),
and cannabis (5%). Below, we describe the five themes.
Physical complications from drug withdrawal: weakness and
lethargy, physical pain, sexual dysfunction, and insomnia
For some participants, the physical complications of
drug withdrawal during the reentry situation were re-
lated to relapse. Participants identified multiple physical
problems, such as weakness and lethargy, body pain,
sexual dysfunction, and insomnia, combined with limited
access to care. One participant said that the biggest
threats to her health after opioid withdrawal were body
pain and insomnia combined with continuity of craving:
“[The major threat] to my health [after drug
withdrawal]? I’m having bone pain, and I cannot bear
it... My pain tolerance is low like that... I am almost
tempted to reuse because of [the] pain and insomnia.
I nearly went into a coma” (P7; 36 years old, divorced,
high school education, an opioid user).
Respondents also believed that the use of illicit drugs
improved their sexual relationships with their partners
and that the sudden lack of such improved relationships
Table 1 Descriptive statistics of participants (n = 20)
Variable Number %
Job
Full time 1 5
Part time 6 30
Jobless 13 65
Marriage
Single 2 10
Marriage 14 70
Separated or divorced 4 20
Age
20< 3 15
20–35 11 55
35–50 6 30
Main drug
Opium 12 60
Tramadol 4 20
Cannabis 4 20
Injection
Yes 5 25
No 15 75
Poly substance use
Yes 16 80
No 4 20
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was responsible for their early consumption of illicit
drugs after withdrawal. For example, one woman
explained,
“For seven months after withdrawal, my husband was
always unhappy about our sexual relationship... I have
a lot of sexual pleasure when I use amphetamine … I
started to reuse amphetamine...” (P4; 39 years old,
married, university education, an amphetamine
and opioid user).
If people are dependent on a substance, withdrawal
symptoms will begin when the substance is removed.
For several people with a substance use disorder, it is
quite difficult and inadvisable for them to try to effect-
ively navigate a withdrawal period. For many people who
use drugs, the painful physical complications of with-
drawal (such as weakness, lethargy, body pain, sexual
dysfunction, and insomnia) lead to continued drug use
and impede the decision to start recovery.
Psychological burden from drug withdrawal: temptation,
craving, inability to bear pressure, coping with stress,
feelings of frustration, failure, adaptation problems to
societal norms, anxiety
Temptation and craving occurred unexpectedly. One
woman with a history of heroin dependence explained
her psychological difficulties, such as frustration and
hopelessness, after her drug withdrawal:
“I was tempted a lot. When I got into something
stimulating or when I was faced with a bad situation,
I indeed didn’t know how I could help myself, and
often the motivation to use [drugs] came from nowhere”
(P2; 47 years old, divorced, primary school education,
a heroin user).
Craving occurred automatically. Some participants de-
scribed the desire to consume illicit drugs while they
were in withdrawal.
“I could escape the conscious desire, as long as the
physical pain wasn’t that intense. There’s a tendency
for drug use... I don’t know why that craving could not
be omitted … The desire to use drugs is still there...
When in a bad state, I want to use illicit drugs. There
is no way to resist” (P4; 39 years old, married, university
education, a heroin user).
Social pressure is one of the reasons that women re-
lapse. One woman said,
“I feel inferior. I am unemployed, [have been] rejected
by my family, and feel a deep sense of loneliness.
There is a lot of pressure on me. I think that I can’t
handle all this pressure … The most convenient way
to forget all my problems and have a good sense of
self-esteem is using drugs” (P31; 43 years old, di-
vorced, primary school education, an opium user).
Stressful events that stimulate negative emotions, such
as the deaths of relatives, also lead to relapse.
“I might not have reused heroin after abstinence if my
father had not died. He supported me in facing my
problems” (P9; 34 years old, primary school education,
married, crack heroin user).
Table 2 Main themes and sub themes
Themes Subthemes
Physical complications
from drug withdrawal
Weakness and lethargy
Physical pain
Sexual dysfunction
Insomnia
Psychological burden from
drug withdrawal
Temptation
Craving
Inability to bear pressure
Coping with stress
Feelings of frustration
Failure
Adaptation problems to societal norms
Anxiety
Contributing factors from
family atmosphere
Rejection by family
Lack of family support
Family conflicts
Divorce
Neglect from family
Addiction in the family
Spousal betrayal
Failure to maintain romantic relationships
Socioeconomic Conditions Interaction with people with a substance
use disorder
Lake of appropriate treatment
Easy access to drugs
Rejection from friends
Unemployment
Poverty
Low cost of drugs
Cultural Factors Stigmatization
Misconceptions about recreational drug use
Sexual disharmony and power imbalance
between treatment provider and client
Discrimination
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For some participants, failure in romantic relationships
was closely linked with their drug use problems.
“My biggest challenge after five months of recovery is
that I cannot accomplish my work and life without
love. You know, I was going to die even if [he]
returned …” (P9; 34 years old, primary school
education, married, crack heroin user).
Psychological factors (such as temptation, craving, so-
cial pressure, stressful events, frustration and hopeless-
ness, failure, feelings of anxiety, and romantic failure)
often lead to relapse. Based on participants’ beliefs, it
seems that some women with a substance use disorder’
recurrent craving for drugs is likely to be shaped after
detoxification; consequently, it is necessary to find suit-
able treatments to stop such craving. In this regard, psy-
chological and educational services can be supportive.
Contributing factors from family atmosphere: rejection by
family, lack of family support, family conflicts, divorce,
neglect from family, addiction in the family, spousal
betrayal, and failure to maintain romantic relationships
Most participants said that a lack of family support dur-
ing times of abstinence impacted their relapse. They
spoke about many aspects of alienation, such as living
alone, living away from family members, being rejected
by family, having family conflicts, being neglected by
family, getting divorced, and being betrayed by their
husbands. One woman explained the need for family
support to prevent her relapse into drug use:
“Many times I felt that I required support, but I
didn’t receive it. I think I want to get support from
my family; otherwise, I’m tempted to use drugs
again because I feel abandoned” (P10; 31 years
old, divorced, primary school education, an
opium user).
A participant also clarified the effect of family conflicts
on her frustration in the context of drug use:
“I want to use [drugs] sometimes when I feel alone,
when I am bad tempered due to my family conflicts,
and my mood is better when I use [drugs] again...”
(P13; 40 years old, married, primary school
education, an opium user).
“I participated in MMT. But a major barrier was
that my family had a negative attitude toward
methadone. They think of methadone as an
addictive drug like crack or opium … They think
I am still an addict...” (P16; 29 years old, high school
education, divorced, an opium user).
The same participant said that the contextual and social
challenges she faced compelled her to use illicit drugs:
“The biggest challenge that I am facing right now
in my life is my divorce. I cannot deal with this
much stress when I have an upset mind. You
know, even when I use, it makes me feel better …”
(P16; 29 years old, high school education, divorced,
an opium user).
Some participants explained how they relapse into
drug use a short time after going through withdrawal.
Participants described an overwhelming urge to use
illicit drugs because they felt neglected by their
families.
“If my family had paid more attention to me and
supported me [in going] to a clinic for drug withdrawal,
perhaps I could have overcome my problems and the
effects of drug withdrawal. In that case, I may have
quit illicit drugs without suffering much” (P16; 29 years
old, high school education, divorced, opium user).
Participants also believed that the illicit drugs used by
some of their family members motivated their own relapse.
“After [quitting drugs], I lived with my grandmother
for a few months. My grandmother used opium. I
heated the brazier for my grandmother and took a
few puffs. Sometimes, I collected all the remains of
the burned opium, and I hid [them] from her. It felt
good using this stolen opium” (P10; 31 years old,
divorced, primary school education, an opium user).
One of the participants noted that she relapsed and
reused illicit drugs as a result of her husband betraying her.
“I fell in love with my husband and he loved me,
too...after my addiction, and when I went to MMT,
my husband betrayed me... For me, everything ended
[in] that moment. I tried to reuse illicit drugs by any
means...” (P13; 40 years old, married, primary
school education, an opium user).
In sum, relapse of drugs is a significant social and
personal problem that is impacted by the family atmos-
phere, including rejection by family, lack of family sup-
port, family conflicts, divorce, family neglect, addiction
in the family, and husband betrayal. Still, the family
often remains the main source of attachment, support,
and socialization for drug users in the process of treat-
ment. Thus, the impact of family members’ support
during the treatment process of substance use must be
considered.
Khazaee-Pool et al. Substance Abuse Treatment, Prevention, and Policy           (2019) 14:27 Page 5 of 11
Socioeconomic conditions: interaction with other people
with a substance use disorder, lake of appropriate
treatment, easy access to drugs, rejection from friends,
unemployment, poverty, and low cost of drugs
Relapse happens in a context of unfavorable social condi-
tions and poor economic resources. Almost all partici-
pants had feelings of being judged negatively by relatives
and others in society. The most difficult problem one par-
ticipant who relapsed faced was living with people with
whom she had a history of drug use. Friends who use illicit
drugs have also been known to be an excuse for using
illicit drugs again. Several participants explicitly men-
tioned the role of friends’ drug use. One woman stated
that her friend influenced her to reuse illicit drugs. She
said that having direct relationships with addicted friends
is associated with a substantial risk of relapse:
“I have several close friends. Some of them were
involved in drug trafficking and drug deals and almost
convinced me to reuse illicit drugs” (P8; 34 years old,
primary school education, single, an opium user).
Almost all women faced financial difficulties, and
many women considered their poor financial situations
to be accelerating their relapse. Because most of them
are unemployed and members of poor families, they do
not have enough money to continue treatment, and, as a
result, they relapse.
“Due to the stressful conditions after drug withdrawal
and the lack of support, most of us relapse in the first
three months. There’s no financial support to get
medical supplies or even to buy food” (P18, 41 years
old, divorced, secondary school education, an opium
user).
Having financial difficulties and easy access to illicit
drugs tempted those without full-time work during with-
drawal to relapse.
“I have no permanent job. I must get money from
anyone I can. My boyfriend gives me money instead of
selling illicit drugs for him...” (P10; 31 years old,
divorced, primary school education, an opium user).
Some participants noted that the exposure to illicit
drugs was the main problem they faced. Furthermore,
easy access and the low cost of illicit drugs in their pre-
vious living environment were considered to be major
challenges to sobriety. For instance, one woman whose
drug involvement led to her imprisonment said,
“It’s totally out of control because of the low cost of
illicit drugs and easy access to illicit drugs every single
day, on the corners...” (P18, 41 years old, divorced,
secondary school education, an opium user).
Generally, several socioeconomic challenges had a
strong influence on these women’s relapse into drug use.
Another participant said,
“Before becoming clean, I spent hours per day for
preparation and consumption... After being clean, I
lost my friends. [Furthermore], I had a great amount
of time [where] I did not have anything to do. My
joblessness motivated me to rethink my drug use”
(P7; 36 years old, divorced, high school education,
an opioid user).
Unpleasant social situations and poor economic re-
sources could lead to relapse, which was reported in al-
most all interviews. Obviously, illicit drug use results in an
important socioeconomic problem and has been related
to a range of negative consequences such as reduced edu-
cational attainment, unemployment, and poverty.
Cultural factors: stigmatization, misconceptions about
recreational drug use, sexual disharmony and power
imbalance between treatment provider and client, and
discrimination
Stigmatization was especially difficult for women who
tried to stay away from illicit drugs. These women men-
tioned that they were seen as drug-addicted persons,
despite their sobriety, and were continuously stigma-
tized. They believed that it was nearly impossible to hide
their previous lives as addicted women. They refused to
go to treatment centers because of their fear of being
labeled as addicted women who had prostituted them-
selves to buy illicit drugs. Relatives and even close family
members distrusted them and deprived them of any sup-
port. For instance, one woman said,
“Even when I abandoned illicit drugs, others
wouldn’t accept it. When I went out into the
community, many people stigmatized me. Relatives …
they did not look at me … They still felt ashamed
to be connected with me. Some didn’t trust me.
I felt that I had no close friends at that time. I
hate going to the drug treatment center. I feel
all the people looking at me as if I am a harlot or
prostitute” (P1; 31 years old, single, an opium user).
The women said that they were suffering from
stigmatization. They found it almost impossible to hide
their lives as addicted women. Some clinics did not accept
them due to the need to prevent future problems. Some
were faced with sexual requests from patients at a number
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of facilities, which created a feeling of insecurity that re-
sulted in a lack of follow-up appointments by women.
“I went to a clinic for treatment. Unfortunately, I faced
several shameless requests: sexual offers. I do not want
to go to a camp or a clinic for treatment. These places
have nothing more than negative views of me and
others like me... They believe that addicted persons
have bad character and are valueless in a community.
Knowing that I am addicted is an ignominy and gives
me a sense of shame …” (P7; 36 years old, divorced,
high school education, an opioid user).
Sexual disharmony between treatment provider and
client was also reported by some participants. The
women believed that the lack of female-specific treat-
ment services affected their treatment outcomes.
“I have previously visited a methadone treatment
center with a male employee. I felt uncomfortable with
him. I felt so ashamed around him. When [he was]
talking or laughing with colleagues, I felt [that] he [was
mocking] me. That’s why I left methadone treatment.
I wish women worked there instead; I feel like treatment
would be easier that way” (P19; 50 years old, married,
high school education, an opium user).
Some women reported experiencing discrimination
and inequality in the delivery of health care between
men and women. From their viewpoint, society’s view of
addicted women is different from that of addicted men.
The perspective of addicted women is related to relapse.
“All addiction treatment centers are dedicated to
men in this city, except one camp that is specifically
for women. I do not [feel] comfortable going to the
methadone clinic” (P10; 31 years old, divorced,
primary school education, an opium user).
Substance use disorder and relapse are often treated as
a negative issue affected by cultural factors such as
stigmatization, sexual disharmony between treatment
provider and client, and discrimination. Not only has
using specific substances resulted in social dissatisfaction
and moral blame, but society has also identified such be-
haviors as offenses. Therefore, the social processes and
institutions that are made to control substance use
might, in fact, take part in its continuity.
Discussion
To the best of our knowledge, this is the first qualitative
study to explore the relapse experiences of Iranian
women with a substance use disorder.
Based on the personal stories of female drug users re-
garding their relapses, we identified five themes that con-
tributed to relapse: physical complications of drug
withdrawal, the psychological burden to quit, family at-
mosphere, socioeconomic conditions, and cultural factors.
Physical complications from drug withdrawal
Our findings indicate that the physical complications of
drug withdrawal are the most important factors in the
relapse into drug use of women with a substance use
disorder. Previous studies confirmed that relapse is com-
mon in women [13, 14, 20]. Women are vulnerable to
relapse because during the process of leaving drugs, they
experience severe withdrawal symptoms [21–23]. As de-
scribed by Hudson and Stamp [22], withdrawal symp-
toms tempt women to relapse. It is worthwhile to
mention that not only is pain common in people with a
substance use disorder, but it is related to addiction
treatment outcome [24]. In addition, perceived pain is
related to increased methadone dose in patients follow-
ing MMT for reducing pain complications [25]. Women
are more susceptible to pain-based withdrawal [23].
Higher sensitivity to pain among women increases risk
of relapse [26]. It has been demonstrated that pain man-
agement strategies have a positive effect on treatment
outcomes [27]. This fact thus supports the value of pain
management intervention to reduce the risk of relapse
among women with a substance use disorder [28]. Add-
itionally, for women in the postpartum period, proges-
terone therapy seems to be associated with a reduction
in cocaine relapse [29].
Hudson and Stamp stated that ovarian hormones
might contribute to relapse in women. In their study,
women were vulnerable to relapse during the late luteal
phase of the ovulation cycle [22]. Thus, it is recom-
mended that relapse prevention programs designed for
women take this stage of their ovulation cycle into
consideration.
Psychological burden from drug withdrawal
Another important finding of this study is that the psy-
chological burden of drug withdrawal is related to re-
lapse. This finding is consistent with a study conducted
by Johnson and colleagues [30], who found that female
cocaine users with depression are at more risk of relapse.
A significantly higher proportion of psychiatric disorders
has been seen in female drug users, and negative feel-
ings, such as comorbid anxiety syndrome, depression,
stress disorders, and experience of loneliness predispose
female drug users to relapse [31, 32]. Psychiatric disor-
ders might complicate treatment outcome in women
[33]. One study revealed that patients with depressive
disorders were 55% less likely to continue a treatment
program [34]. This result suggests the need to develop
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psychological assessments that enable a quick diagnosis
and immediate treatment for psychiatric disorders in fe-
male drug users. The treatment of mental disorders pro-
vided by a trained mental health team could improve
retention in women with a substance use disorder [35].
Additionally, women who reported experience of phys-
ical and sexual abuse in their life were at risk of relapse
in the treatment period [13, 36]. Furthermore, teaching
women skills that emphasize coping with craving, anger
management, relaxation, life skills, and meditation might
be useful.
Contributing factors from family atmosphere
Another influential factor related to relapse in women
with a substance use disorder is the family atmosphere.
The findings of our study emphasize the importance of
the role of family and relatives in the outcome of treat-
ment. Our study revealed that 63% of participants lived
with someone, either a family member or a partner, who
had drug-related problems.
This finding is in line with those of other studies. Dolan
and colleagues reported that 53% of Iranian women with a
substance use disorder had a partner with a drug use dis-
order [9]. In this study, we found that husbands play an
important role in relapse and drug use. There is contra-
dictory information in this regard. This association was
also reported by other authors who found that living with
family members with drug use disorders increases the
probability of relapse [37, 38]. However, one study result
showed that living with a spouse or partner who uses illicit
drugs predicts a reduced probability of relapse [39]. Briggs
and colleagues suggested that recovery from drug use in
women with a substance use disorder positively contrib-
utes to a relationship [40].
Although a previous study demonstrated that male part-
ners play a significant role in women’s drug use and seek-
ing of treatment [41], according to a study by Johnson and
colleagues, women with a substance use disorder were dis-
appointed by their partners when seeking treatment [30].
Some studies have shown the reverse, where men encour-
age and support their partners to seek treatment [40, 42].
Even though Soyez and colleagues found better treatment
outcomes in females with more social support [43],
women with a substance use disorder would like to be iso-
lated from others because of feelings of stigma [44, 45].
Isolation and lack of social support are related to more
risk for relapse among women. This indicates that em-
phasis should be given to counseling of couples in the de-
velopment of a relapse prevention program.
Socioeconomic conditions
Several socioeconomic characteristics have an effect on
treatment outcome and relapse. Most of the participants
in this study live in undesirable socioeconomic conditions:
They have limited levels of education, are unemployed,
live in poverty, experience conflicts, and have a history of
drug abuse and criminal activity in their families. This
finding is consistent with the results of other studies that
focused on relapse [21, 46]. In low socioeconomic condi-
tions, women with a substance use disorder face many dif-
ficulties in accessing treatment. These limitations make it
difficult for women to change their lives. Our findings
suggest that interventions should be designed to increase
the empowerment of women and to enable them to con-
trol their lives.
The findings of previous studies showed that a lack of
financial resources is common in Iranian women with a
substance use disorder [47, 48]. Several characteristics
are related to drug recovery in women and have an im-
pact on treatment outcome and relapse, including atti-
tudes toward treatment [49], negative expectations
regarding treatment outcome [50], a lack of access to
gender-appropriate treatment [51], treatment costs [52],
pregnancy difficulty, and child care [53].
According to our study, over 90% of participants have
applied self-abstinence in the past in an attempt to quit
illicit drugs. One explanation for this is that Iranian
women with a substance use disorder feel uncomfortable
seeking treatment because there is a lack of appropriate
services for women. Therefore, women with a substance
use disorder who seek treatment face problems. Treat-
ment cost seems to be another barrier for women. Some
of the participants in this study indicated that they
dropped out of the treatment program because they
could not pay the costs. In Iran and several other coun-
tries, people with a substance use disorder cannot rely
on their insurance to cover drug abuse treatment. How-
ever, when people with a substance use disorder are un-
able to afford drug treatment, they might drop out of
the treatment program and start to use illicit drugs
again. Addiction treatment features are related to reten-
tion in treatment among women [53]. Studies have
shown that there are complementary therapies. Counsel-
ing on domestic violence, free services for transporta-
tion, and child care services have proven to be effective
in the retention of treatment [54, 55].
Cultural factors
Most of the participants in this study have dropped out
of treatment at least one time. They did not want to
continue their treatment for several reasons. For in-
stance, feelings of embarrassment and shame and
stigmatization are barriers to going to drug treatment
centers. Dolan and colleagues stated that stigma is one
of the main barriers to seeking treatment in Iranian
women with a substance use disorder [9]. This finding is
in line with other studies on drug abuse [56–58]. Stigma
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and social barriers might deter the demand for drug re-
covery programs [59].
According to our findings, the participants in this
study were referred to mixed-gender centers, which
employed male therapists, to receive treatment services.
Although many studies found no relationship between
the gender of the patient and therapist and the outcome
of the patient [60, 61], the results of this study suggest
that women with a substance use disorder are more
comfortable receiving treatment services from female
therapists. Messina and colleagues suggested that
women with drug disorders were more satisfied when
they went to drug treatment centers with female staff
[62]. Women with a substance use disorder in female-
specific treatment have better outcomes than those in
mixed-gender treatment [63]. Also gender-specific treat-
ment is related to higher feelings of safety and comfort
among women [64]. This is not surprising, considering
the fact that women fear experiencing sexual harassment
from men. As such, we suggest developing gender-
specific drug treatment centers and culturally sensitive
approaches to stigma in Iran. In addition, innovation in
addiction treatments and applying new methods could
result in lower stigma and fewer treatment barriers
among women who seek treatment [65].
This study is also subject to some limitations. First, a
limitation is that data were obtained from a limited num-
ber of women who sought treatment and who were re-
ferred to a drug treatment setting, such as medium-term
residential centers, MMT centers, and women’s prisons.
For that reason, the results cannot be generalized to other
groups of patients with drug use disorders. A second limi-
tation, inherent to all qualitative studies, is that the pres-
ence of the interviewer might have encouraged the
respondents to take social norms into account when an-
swering questions. Pressure to conform to social norms
can lead to the underreporting of socially undesirable be-
havior and to the over reporting of socially desirable
behavior. However, in this study, we used a number of
techniques to avoid this, including triangulation use of
contradictory evidence, respondent validation, and con-
stant comparison. Respondent validation, which allowed
participants in this study to read through the data and
analyses and to provide feedback on the researchers’ inter-
pretations of their responses, provided the researchers a
method to check for inconsistencies and an opportunity
to reanalyze the data. Despite these limitations, this study
provides rich and in-depth information regarding women
with a substance use disorder in an Iranian community.
Conclusions
The findings of this study highlight that women may
face many barriers for addiction treatment, such as
stigma, discrimination, a lack of access to treatment
services, and financial problems. Our findings are in line
with research that revealed that women have physiolo-
gically, psychologically, and culturally unique features
with regard to the addiction process, treatment, and
maintenance of recovery [22]. Given the lack of female
staff in treatment centers, having comprehensive treat-
ment programs conducted by female employees seems
an opportune way to make addicted women feel more at
ease. Furthermore, policymakers should be committed
to providing a nonjudgmental social environment to re-
move or reduce stigma in public communities toward
women with drug use disorders, and the development of
treatment-based insurance might encourage women to
undergo treatment.
Abbreviations
DSM-V: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition;
HIV: Human immunodeficiency virus; MMT: Methadone Maintenance Therapy;
UNODC: United Nations Office on illicit drugs and Crime
Acknowledgments
This paper was extracted from an MS Thesis in health education prepared by
Mrs. Roghaye Nouri entitled “The Study of Relapse Factors in women with
substance dependence in Sanandaj City.” We would like to thank all subjects
for their participation in the current project. Also, we highly appreciate the
support received from the deputy of research and technology at Kurdistan
University of Medical Sciences [Grant number 14/23312].
Authors’ contributions
TP was the main investigator, designed the project, and collected the data. MK and
TP did the statistical analysis and wrote the first draft of the manuscript. RN and PT
contributed to the statistics. KP contributed substantially to the interpretation of the
data and critically revised the final article. All authors read and approved the final
manuscript.
Funding
The study was funded by Kurdistan University of Medical Sciences (KUMS).
Availability of data and materials
The datasets generated and analyzed during the current study are not publicly
available in order to protect the participants’ anonymity but are available from
the corresponding author on reasonable request.
Ethics approval and consent to participate
Approval to conduct the study was granted by the Ethics Committee of Kurdistan
University of Medical Sciences, Kurdistan, Iran. Informed written consent was
received from all participants.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Author details
1Department of Public Health, School of Health, Mazandaran University of
Medical Sciences, Sari, Iran. 2Health Sciences Research Center, Addiction
Research Institutes, Mazandaran University of Medical Sciences, Sari, Iran.
3Environmental Health Research Center, Research Institute for Health
Development, Kurdistan University of Medical Sciences, Sanandaj, Iran.
4Department of public health,Faculty of Health, Kurdistan University of
Medical Sciences, Sanandaj, Iran. 5Department of Communication Sciences,
imec-mict-Ghent University, Ghent, Belgium.
Khazaee-Pool et al. Substance Abuse Treatment, Prevention, and Policy           (2019) 14:27 Page 9 of 11
Received: 24 September 2018 Accepted: 7 June 2019
References
1. Ghane T, Zamani N, Hassanian-Moghaddam H, Beyrami A, Noroozi A. Lead
poisoning outbreak among opium users in the Islamic Republic of Iran,
2016–2017. Bull World Health Organ. 2018;96(3):165–72.
2. Tavakoli M, Mohammadi L, Yarmohammadi M, Farhoudian A, Ja'fari F,
Farhadi MH. Status and trend of substance abuse and dependence among
Iranian women. J Rehabil. 2014;14(5):30–7.
3. Khajedaluee M, Moghadam MD. Methods and patterns of drug abuse
among young addict women. J Res Health. 2013;3:527–35.
4. Ministry of Health and Medical Education. AIDS progress report. Tehran: Iran.
2014. https://www.unaids.org/en/&/country-progress-reports/2014countries.
Accessed 11 Dec 2014.
5. Greenfield SF, Brooks AJ, Gordon SM, Green CA, Kropp F, McHugh RK,
Lincoln M, Hien D, Miele GM. Substance abuse treatment entry, retention,
and outcome in women: a review of the literature. Drug Alcohol Depend.
2007;86(1):1–21.
6. Brady TM, Ashley OS. Women in substance abuse treatment: results from
the alcohol and drug services study (ADSS): Citeseer; 2005.
7. UNODC. World drug report. New York: United Nations; 2015.
8. Lal R, Deb KS, Kedia S. Substance use in women: current status and future
directions. Indian J Psychiatry. 2015;57(Suppl 2):S275.
9. Dolan K, Salimi S, Nassirimanesh B, Mohsenifar S, Allsop D, Mokri A.
Characteristics of Iranian women seeking drug treatment. J Women’s
Health. 2011;20(11):1687–91.
10. Wright S. Women’s use of drugs: gender specific factors. Drug misuse and
motherhood; 2002. p. 15–31.
11. Dolan K, Salimi S, Nassirimanesh B, Mohsenifar S, Allsop D, Mokri A. Six-
month follow-up of Iranian women in methadone treatment: drug use,
social functioning, crime, and HIV and HCV seroincidence. Subst Abuse
Rehabil. 2012;3(Suppl 1):37–43.
12. Domino KB, Hornbein TF, Polissar NL, Renner G, Johnson J, Alberti S, et al.
Risk factors for relapse in health care professionals with substance use
disorders. Jama. 2005;293(12):1453–60.
13. Becker JB, Molenda H, Hummer DL. Gender differences in the behavioral
responses to cocaine and amphetamine. Implications for mechanisms mediating
gender differences in drug abuse. Ann N Y Acad Sci. 2001;937:172–87.
14. Elman I, Karlsgodt KH, Gastfriend DR. Gender differences in cocaine craving
among non-treatment-seeking individuals with cocaine dependence. Am J
Drug Alcohol Abuse. 2001;27(2):193–202.
15. Graneheim UH, Lundman B. Qualitative content analysis in nursing research:
concepts, procedures and measures to achieve trustworthiness. Nurse Educ
Today. 2004;24(2):105–12.
16. Abdollahi Z, Taghizadeh F, Hamzehgardeshi Z, Bahramzad O. Relationship
between addiction relapse and self-efficacy rates in injection drug users
referred to maintenance therapy Center of Sari, 1391. Global J Health Sci.
2014;6(3):138.
17. Jalali A, Seyedfatemi N, Peyrovi H. Relapse model among Iranian drug users:
a qualitative study. Int J Community Based Nurs Midwifery. 2015;3(1):2.
18. Seyedfatemi N, Peyrovi H, Jalali A. Relapse experience in Iranian opiate users: a
qualitative study. Int J Community Based Nurs Midwifery. 2014;2(2):85.
19. Wildemuth B, Zhang Y. Qualitative analysis of content; 2009.
20. Becker JB, Hu M. Sex differences in drug abuse. Front Neuroendocrinol.
2008;29(1):36–47.
21. Yang M, Mamy J, Gao P, Xiao S. From abstinence to relapse: a preliminary
qualitative study of drug users in a compulsory drug rehabilitation Center in
Changsha, China. PLoS One. 2015;10(6):e0130711.
22. Hudson A, Stamp JA. Ovarian hormones and propensity to drug relapse: a
review. Neurosci Biobehav Rev. 2011;35(3):427–36.
23. Mack KA, Jones CM, Paulozzi L. Vital Signs: Overdoses of Prescription Opioid
Pain Relievers and Other Drugs Among Women—United States, 1999–2010.
MMWR—Morb Mortal Wkly Rep. 2013;62(26):537–42.
24. Dhingra L, Masson C, Perlman DC, Seewald RM, Katz J, McKnight C, et al.
Epidemiology of pain among outpatients in methadone maintenance
treatment programs. 2013;128(1–2):161–5.
25. Peles E, Schreiber S, Gordon J, Adelson MJP. Significantly higher methadone
dose for methadone maintenance treatment (MMT) patients with chronic
pain. 2005;113(3):340–6.
26. Doweiko H. Concepts of chemical dependency: Nelson education; 2011.
27. Barry DT, Beitel M, Joshi D, Schottenfeld RS. Pain and substance-related
pain-reduction behaviors among opioid dependent individuals seeking
methadone maintenance treatment. Am J Addict. 2009;18(2):117–21.
28. McHugh RK, Votaw VR, Sugarman DE, Greenfield SF. Sex and gender
differences in substance use disorders. Clin Psychol Rev. 2018;66:12–23.
29. Yonkers KA, Forray A, Nich C, Carroll KM, Hine C, Merry BC, et al. Progesterone for
the reduction of cocaine use in post-partum women with a cocaine use disorder:
a randomised, double-blind, placebo-controlled, pilot study. 2014;1(5):360–7.
30. Johnson JE, O'Leary CC, Striley CW, Abdallah AB, Bradford S, Cottler LB.
Effects of major depression on crack use and arrests among women in drug
court. Addiction. 2011;106(7):1279–86.
31. Kushner MG, Donahue C, Sletten S, Thuras P, Abrams K, Peterson J, et al.
Cognitive behavioral treatment of comorbid anxiety disorder in alcoholism
treatment patients: presentation of a prototype program and future
directions. J Ment Health. 2006;15(6):697–707.
32. McLellan AT, Luborsky L, Woody GE, O'Brien CP, Druley KA. Predicting
response to alcohol and drug abuse treatments: role of psychiatric severity.
Arch Gen Psychiatry. 1983;40(6):620–5.
33. Greenfield SF, Grella CE. What is “women-focused” treatment for substance
use disorders? Psychiatr Serv. 2009;60(7):880–2.
34. Gray AR, Saum CA. Mental health, gender, and drug court completion. Am J
Crim Justice. 2005;30(1):55–69.
35. Morse DS, Cerulli C, Bedell P, Wilson JL, Thomas K, Mittal M, et al. Meeting
health and psychological needs of women in drug treatment court. J Subst
Abus Treat. 2014;46(2):150–7.
36. Hyman SM, Paliwal P, Chaplin TM, Mazure CM, Rounsaville BJ, Sinha RJD, et
al. Severity of childhood trauma is predictive of cocaine relapse outcomes
in women but not men. 2008;92(1–3):208–16.
37. Kelly JF, Stout RL, Greene MC, Slaymaker V. Young adults, social networks,
and addiction recovery: post treatment changes in social ties and their role
as a mediator of 12-step participation. PLoS One. 2014;9(6):e100121.
38. Grella CE. From generic to gender-responsive treatment: changes in social
policies, treatment services, and outcomes of women in substance abuse
treatment. J Psychoactive Drugs. 2008;40(sup5):327–43.
39. Ellis B, Bernichon T, Yu P, Roberts T, Herrell JM. Effect of social support on
substance abuse relapse in a residential treatment setting for women. Eval
Program Plann. 2004;27(2):213–21.
40. Briggs CA, Pepperell JL. Women, girls, and addiction: celebrating the
feminine in counseling treatment and recovery: Taylor & Francis; 2009.
41. Powis B, Griffiths P, Gossop M, Strang J. The differences between male and
female drug users: community samples of heroin and cocaine users
compared. Subst Use Misuse. 1996;31(5):529–43.
42. Substance Abuse and Mental Health Services Administration. Substance Abuse
Treatment: Addressing the Specific Needs of Women. Treatment Improvement
Protocol (TIP) Series, No. 51. HHS Publication No. (SMA) 13-4426. Rockville:
Substance Abuse and Mental Health Services Administration, 2009.
43. Soyez V, De Leon G, Broekaert E, Rosseel Y. The impact of a social network
intervention on retention in Belgian therapeutic communities: a quasi-
experimental study. Addiction. 2006;101(7):1027–34.
44. Becker JB, McClellan ML, Reed BG. Sex differences, gender and addiction. J
Neurosci Res. 2017;95(1–2):136–47.
45. Swanepoel I, Geyer S, Crafford GJSW. Risk factors for relapse among young
African adults following in-patient treatment for drug abuse in the Gauteng
Province. 2016;52(3):414–38.
46. Maehira Y, Chowdhury EI, Reza M, Drahozal R, Gayen TK, Masud I, et al. Factors
associated with relapse into drug use among male and female attendees of a
three-month drug detoxification–rehabilitation programme in Dhaka,
Bangladesh: a prospective cohort study. Harm Reduct J. 2013;10(1):1.
47. Tolman RM, Warner LA, Rosen D. Low-income women's use of substance abuse
and mental health services. J Health Care Poor Underserved. 2004;15(2):206–19.
48. Montoya ID, Atkinson JS. A synthesis of welfare reform policy and its impact
on substance users. The Am J Drug Alcohol Abuse. 2002;28(1):133–46.
49. Wu LT, Ringwalt CL. Alcohol dependence and use of treatment services
among women in the community. Am J Psychiatry. 2004;161(10):1790–7.
50. Kline A. Pathways into drug user treatment: the influence of gender and
racial/ethnic identity. Subst Use Misuse. 1996;31(3):323–42.
51. Azim T, Bontell I, Strathdee SA. Women, drugs and HIV. Int J Drug Policy.
2015;26:S16–21.
52. Olsen A, Banwell C, Dance P, Maher L. Positive health beliefs and
behaviours in the midst of difficult lives: women who inject drugs. Int J
Drug Policy. 2012;23(4):312–8.
Khazaee-Pool et al. Substance Abuse Treatment, Prevention, and Policy           (2019) 14:27 Page 10 of 11
53. Tuchman E. Women and addiction: the importance of gender issues in
substance abuse research. J Addict Dis. 2010;29(2):127–38.
54. Nelson-Zlupko L, Dore MM, Kauffman E, Kaltenbach K. Women in recovery. Their
perceptions of treatment effectiveness. J Subst Abuse Treat. 1996;13(1):51–9.
55. Strauss SM, Falkin GP. The relationship between the quality of drug user
treatment and program completion: understanding the perceptions of
women in a prison-based program. Subst Use Misuse. 2000;35(12–14):2127–59.
56. El-Bassel N, Shaw SA, Dasgupta A, Strathdee SA. Drug use as a driver of HIV
risks: re-emerging and emerging issues. Curr Opin HIV AIDS. 2014;9(2):150–5.
57. Otiashvili D, Kirtadze I, O’Grady KE, Zule W, Krupitsky E, Wechsberg WM, et al.
Access to treatment for substance-using women in the republic of Georgia:
socio-cultural and structural barriers. Int J Drug Policy. 2013;24(6):566–72.
58. Grella CE. Services for perinatal women with substance abuse and mental
health disorders: the unmet need. J Psychoactive Drugs. 1997;29(1):67–78.
59. Simpson M, McNulty J. Different needs: Women's drug use and treatment in
the UK. Int J Drug Policy. 2008;19(2):169–75.
60. McKay JR, Lynch KG, Pettinati HM, Shepard DS. An examination of potential
sex and race effects in a study of continuing Care for Alcohol-and Cocaine-
Dependent Patients. Alcohol Clin Exp Res. 2003;27(8):1321–3.
61. Sterling RC, Gottheil E, Weinstein SP, Serota R. Therapist/patient race and
sex matching: treatment retention and 9-month follow-up outcome.
Addiction. 1998;93(7):1043–50.
62. Messina N, Calhoun S, Warda U. Gender-responsive drug court treatment: A
Randomized Controlled Trial. Crim Justice Behav. 2012;39(12):1539–58.
63. Niv N, Hser Y-IJD. Women-only and mixed-gender drug abuse treatment
programs: service needs, utilization and outcomes. Drug Alcohol Depend.
2007;87(2-3):194–201.
64. Greenfield SF, Kuper LE, Cummings AM, Robbins MS, Gallop RJ. Group Process
in the single-gender Women's Recovery Group compared with mixed-gender
Group Drug Counseling. J Groups Addict Recover. 2013;8(4):270–93.
65. Meyer JP, Isaacs K, El-Shahawy O, Burlew AK, Wechsberg WJD. Research on
Women with Substance Use Disorders: Reviewing Progress and Developing a
Research and Implementation Roadmap. Drug Alcohol Depend. 2019;197:158–63.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published
maps and institutional affiliations.
Khazaee-Pool et al. Substance Abuse Treatment, Prevention, and Policy           (2019) 14:27 Page 11 of 11
